BioPlus Acquisition Corp. (BIOS)
10.79
-0.01 (-0.09%)
At close: Oct 06, 2023, 7:46 PM
Company Description
BioPlus Acquisition Corp. does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry.
The company was incorporated in 2021 and is based in New York, New York.
BioPlus Acquisition Corp.
| Country | United States |
| IPO Date | Jan 28, 2022 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | R. Ross Haghighat |
Contact Details
Address: 260 Madison Avenue New York, New York United States | |
| Website | https://bioplusspac.com |
Stock Details
| Ticker Symbol | BIOS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001856653 |
| CUSIP Number | 09069N108 |
| ISIN Number | KYG112171171 |
| Employer ID | 98-1583272 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| R. Ross Haghighat | Chief Executive Officer, Chief Financial Officer & Director |
| Ross Haghighat | Chief Executive Officer, Chief Financial Officer & Director |
| Jonathan M. N. Rigby MBA | Chairman & Chief Bus. Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 09, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 07, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 19, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 16, 2023 | 15-12G | Filing |
| Oct 06, 2023 | 25-NSE | Filing |
| Oct 04, 2023 | RW | Filing |
| Oct 04, 2023 | 8-K | Current Report |
| Sep 15, 2023 | 425 | Filing |
| Aug 16, 2023 | 425 | Filing |